All filters
Slidesets
A Major Concern Among HIV/AIDS Patients: Polypharmacy | Dr A. Cagkan Inkaya
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Long-term toxicities of commonly prescribed first line regimens, a 10 – 20 year horizon | José Arribas, MD
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Impact of lean mass and bone density on glomerular filtration rate estimation in people living with HIV/aids | Dr C. Isnard Bagnis
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Improved function, strength, quality of life and goal attainment in people living with HIV attending a physiotherapy-led group rehabilitationintervention in the UK | Dr D. Brown
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Caring for the aging HIV infected patient: meeting the challenge | Giovanni Guaraldi, MD
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Healthy Living from the community perspective | Romy Mathys
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Examples of missed opportunities in avoiding long term toxicities and comorbidities | Yazdan Yazdanpanah, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Development of an innovative mHealth application to support selfmanagement strategies for people living with HIV | Dr D. Brown
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Online sexual health intervention to support MSM directly after HIV diagnosis -The experiences of www.4mezelf.nl | Dr U. Davidovich
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
What “good” looks like. Enhancing the well-being of people with HIV through a Peer Navigator Service | Dr J. Anderson
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Missed the PrEP opportunity? | Laura Waters, MD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
PrEP: who, when and how | Anton Pozniak, MD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2016
Slidesets
Raltegravir (RAL) pharmacokinetics (PK) and safety in HIV-1-exposed neonates at high risk of infection (IMPAACT 1110) | Dr. D. Clarke
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
HIV PCR testing at birth in KwaZulu Natal, South Africa – one year post introduction of the largest neonatal HIV testing programme | Dr. F. Moyo
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Switching to second-line antiretroviral therapy in HIV-infected children: a CIPHER cohort collaboration global analysis | Dr. R. Goodall
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Paediatric HIV point of care testing: field evaluation of the performance of Cepheid and Alere qualitative HIV assays in a Soweto academic hospital | Dr. T. Murray
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Low-Resource Perspective on Adolescent Transition and Research Priorities | Mary-Ann Davies, MBChB, MMed, PhD, FC
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
The global epidemiology of perinatally HIV-infected adolescents: A CIPHER Global Cohort Collaboration analysis | Dr. Amy Slogrove
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
It’s Not Just HIV: Complications and Research Priorities in Care of HIV-Infected Youth | Rashida Ferrand, MBBS, MRCP, MSc, DRM&H
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Higher retention and viral suppression rates in dedicated adolescent-friendly HIV clinic in South Africa | Brian Zanoni, MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
High-Resource Perspective on Adolescent Transition and Research Priorities | Ali Judd
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Decreased bone turnover in HIV-infected children on antiretroviral therapy | Dr. S. Shiau
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Does HIV DNA-PCR testing of HIV-exposed infants at birth reduce follow-up for routine testing at 4-14 weeks of age? | Dr. E. Kalk
Presented at:
International Workshop on HIV & Pediatrics 2016
Slidesets
Impact of birth HIV PCR testing on routine 6-week EID testing in Cape Town, South Africa | Dr. L. Dunning
Presented at:
International Workshop on HIV & Pediatrics 2016